The diagnostic value of 18F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis - a prospective study.

Loading...
Thumbnail Image

Embargo End Date

ICR Authors

Authors

Kouijzer, IJE
Scheper, H
de Rooy, JWJ
Bloem, JL
Janssen, MJR
van den Hoven, L
Hosman, AJF
Visser, LG
Oyen, WJG
Bleeker-Rovers, CP
de Geus-Oei, L-F

Document Type

Journal Article

Date

2018-05

Date Accepted

2017-12-10

Abstract

PURPOSE:The aim of this study was to determine the diagnostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) and magnetic resonance imaging (MRI) in diagnosing vertebral osteomyelitis. METHODS:From November 2015 until December 2016, 32 patients with suspected vertebral osteomyelitis were prospectively included. All patients underwent both 18F-FDG-PET/CT and MRI within 48 h. All images were independently reevaluated by two radiologists and two nuclear medicine physicians who were blinded to each others' image interpretation. 18F-FDG-PET/CT and MRI were compared to the clinical diagnosis according to international guidelines. RESULTS:For 18F-FDG-PET/CT, sensitivity, specificity, PPV, and NPV in diagnosing vertebral osteomyelitis were 100%, 83.3%, 90.9%, and 100%, respectively. For MRI, sensitivity, specificity, PPV, and NPV were 100%, 91.7%, 95.2%, and 100%, respectively. MRI detected more epidural/spinal abscesses. An important advantage of 18F-FDG-PET/CT is the detection of metastatic infection (16 patients, 50.0%). CONCLUSION:18F-FDG-PET/CT and MRI are both necessary techniques in diagnosing vertebral osteomyelitis. An important advantage of 18F-FDG-PET/CT is the visualization of metastatic infection, especially in patients with bacteremia. MRI is more sensitive in detection of small epidural abscesses.

Citation

European journal of nuclear medicine and molecular imaging, 2018, 45 (5), pp. 798 - 805

Source Title

Publisher

ISSN

1619-7070

eISSN

1619-7089

Research Team

Translational Molecular Imaging

Notes